NfL can also be measured in blood, where levels are elevated in the prodromal (Mattsson et al, 2017a) and dementia stages (Mattsson et al, 2019) of sporadic AD as well as in autosomal dominant AD (Preische et al, 2019; Quiroz et al, 2020). Here, NEFL is linked to dementia.